Newsletter for July, 2013

MassMEDIC Submits Comments on FDA 510(k) Draft Guidance

This week MassMEDIC submitted its comments on the U.S. Food and Drug Administration (FDA) Center for Devices and Radiological Health’s draft guidance document relative to filing a 510(k) for changes to an existing device.

View MassMEDIC's Letter

 

MassMEDIC Fall Calendar of Events

As a meeting place for the region’s medical device manufacturers and suppliers, MassMEDIC holds a series of informational programs throughout the year on a wide range of topics of interest to MassMEDIC members, including regulatory affairs, product development trends and reimbursement issues.

View Upcoming Events

 

Achieve Your Business Goals and Drive Industry Conversation at AdvaMed 2013: The MedTech Conference

Join over 1,000 companies seeking to influence industry discussion from key perspectives at AdvaMed 2013, the leading MedTech Conference in North America, September 23-25, 2013 in Washington, D.C. AdvaMed 2013 will feature 40+ educational panel sessions, executive forums, networking opportunities, business development presentations, and world-class speakers discussing the most relevant and timely issues for the […]

Read the Article

 

Call for Presentations: MassMEDIC 2013 Medtech Investors Conference

MassMEDIC will host its 14th annual Medtech Investors Conference on Friday November 1, 2013. The daylong program, drawing more than 400 attendees from the financing, consulting and manufacturing sectors, will feature presentations by up to 25 regionally based medical device companies, as well as a breakfast panel discussion and a luncheon keynote address...

Read the Article

 

Upcoming Industry Meetings and Events

Institute of Medical Device Development (IMDD) Training Week, July 15-18, 2013
The 1st International Translational Nanomedicine Conference, July 26-28, 2013

Click for More Info and Links to These Events

 

MedTech Articles of Interest

FDA aims to clear confusion, prevent errors in medtech adverse event reports
Blockbusters and bloodlettings: A look at 2013's hot M&A start
Growing Concern Over Alarm Hazards Signals Need for Change
FDA Clarifies Adverse Event Reporting

Click for Links to Articles